Poly(ethylene) glycol-capped silver and magnetic nanoparticles: Synthesis, characterization, and comparison of bactericidal and cytotoxic effects

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine

Volumn 227, Issue 11, 2013, Pages 1224-1236

  Mandal, A ^a,b   Sekar, S ^b   Chandrasekaran, N ^a   Mukherjee, A ^a   Sastry, T P ^b  

^a VIT UNIVERSITY   (India)

^b CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Bactericide; Cytotoxicity; Magnetic (Fe3O4) nanoparticles; Poly(ethylene) glycol; Silver (Ag) nanoparticles

Indexed keywords

BIOMEDICAL APPLICATIONS; CHEMICAL AND PHYSICAL PROPERTIES; FOURIER TRANSFORM INFRA REDS; MAGNETIC NANO-PARTICLES; PARTICLE SIZE ANALYZERS; SILVER NANOPARTICLES; SPECTROSCOPIC TECHNIQUE; STAPHYLOCOCCUS AUREUS;

AGGLOMERATION; BACTERIA; BACTERICIDES; CELL CULTURE; CYTOTOXICITY; ETHYLENE; FIBROBLASTS; GLYCOLS; MEDICAL APPLICATIONS; NANOMAGNETICS; NANOPARTICLES; PARTICLE SIZE ANALYSIS; PHOTOELECTRONS; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY PHOTOELECTRON SPECTROSCOPY; ANTIMICROBIAL AGENTS; ELECTRONS; MAGNETISM; MICROORGANISMS; PARTICLE SIZE;

SILVER;

ANTIINFECTIVE AGENT; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; SILVER;

3T3 CELL LINE; ANALYSIS OF VARIANCE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MICROBIAL VIABILITY; MOUSE; STAPHYLOCOCCUS AUREUS; TOXICITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; MAGNETITE NANOPARTICLES; MICE; MICROBIAL VIABILITY; NIH 3T3 CELLS; POLYETHYLENE GLYCOLS; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84890502740     PISSN: 09544119     EISSN: 20413033     Source Type: Journal    
DOI: 10.1177/0954411913499290     Document Type: Article

References (62)

1. Rai M, Yadav A and Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 2009; 27: 76-83.
2. Morones JR, Elechiguerra JL, Camacgo A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005; 16: 2346-2353.
3. Silver S and Phung LT. Bacterial heavy metal resistance: new surprises. Annu Rev Microbiol 1996; 50: 753-759.
4. Slawson R, Van Dyke MI, Lee H, et al. Germanium and silver resistance, accumulation and toxicity in microorganisms. Plasmid 1992; 27: 72-79.
5. Touati D. Iron and oxidative stress in bacteria. Arch Biochem Biophys 2000; 373: 1-6.
6. Kheybari S, Samadi N, Hosseini SV, et al. Synthesis and antimicrobial effects of silver nanoparticles produced by chemical reduction method. Daru 2010; 18: 168-172.
7. Shrivastava S, Bera T, Roy A, et al. Characterization of enhanced antibacterial effect of novel silver nanoparticles. Nanotechnology 2007; 18: 225103-225111.
8. Grinholc M, Szramka B, Kurlenda J, et al. Bactericidal effect of photodynamic inactivation against methicillinresistant and methicillin- susceptible Staphylococcus aureus is strain-dependent. J Photochem Photobiol B 2008; 90: 57-63.
9. Michael CH, Warren KR and Kelly PF. Staphylococcus aureus adhesion to bone matrix and bone-associated biomaterials. FEMS Microbiol Lett 1999; 173: 279-284.
10. Mariusz G, Grzegorz W and Julianna K. Evaluation of biofilm production and prevalence of the icaD gene in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains isolated from patients with nosocomial infections and carriers. FEMS Immunol Med Microbiol 2007; 50: 375-379.
11. Harris LG, Tosatti S, Wieland M, et al. Staphylococcus aureus adhesion to titanium oxide surfaces coated with non-functionalized and peptide- functionalized poly(llysine)-grafted-poly(ethylene glycol) copolymers. Biomaterials 2004; 25: 4135-4148.
12. Jevons MP. "Celbenin"-resistant Staphylococci. BMJ 1961; 1: 124-125.
13. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-155.
14. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7: 178-182.
15. Tran N, Mir A, Mallik D, et al. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int J Nanomedicine 2010; 5: 277-283.
16. Gu HW, Xu KM, Xu CJ, et al. Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Comm 2006; 6: 941-949.
17. Roger J, Pons J, Massart R, et al. Some biomedical applications of ferrofluids. Eur Phys J Appl Phys 1999; 5: 321-325.
18. Wunderbaldinger P, Josephson L and Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002; 13: 264-268.
19. Duguet E, Vasseur S, Mornet S, et al. Magnetic nanoparticles and their applications in medicine. Nanomedicine 2006; 1: 157-168.
20. 4 nanoparticles in the cells and organs of lung and liver. Chin Med J 2009; 122: 1821-1825.
21. Kim DH, Lee SH, Im KH, et al. Surface-modified magnetite nanoparticles for hyperthermia: preparation, characterization and cytotoxicity studies. Curr Appl Phys 2006; 6: 242-246.
22. Albornoz C and Jacobo SE. Preparation of a biocompatible magnetic film from an aqueous ferrofluid. J Magn Magn Mater 2006; 305: 12-15.
23. Hoa LTM, Dung TT, Danh TM, et al. Preparation and characterization of magnetic nanoparticles coated with polyethylene glycol. J Phys Conf Ser 2009; 187: 012048-012051.
24. Zhang Y, Kohler N and Zhang MQ. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002; 23: 1553-1561.
25. Mandal A, Meda V, Zhang WJ, et al. Synthesis, characterization and comparison of antimicrobial activity of PEG/TritonX-100 capped silver nanoparticles on collagen scaffold. Colloids Surf B Biointerfaces 2012; 90: 191-196.
26. Sinha A, Nayar S, Murthy GVS, et al. Biomimetic synthesis of superparamagnetic iron oxide particles in proteins. J Mater Res 2003; 18: 1309-1313.
27. Sinha A, Nayar S, Nath BK, et al. Magnetic field induced synthesis and self-assembly of super paramagnetic particles in a protein matrix. Colloids Surf B Biointerfaces 2005; 43: 7-11.
28. Ansari MA, Khan HM, Khan AA, et al. Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med 2011; 3: 141-146.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
30. Khanna PK, Singh N, Charan S, et al. Synthesis and characterization of Ag/PVA nanocomposite by chemical reduction method. Mater Chem Phys 2005; 93: 117-121.
31. Kvitek L, Panacek A, Soukupova J, et al. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C 2008; 112: 5825-5834.
32. Chou KS and Lai YS. Effect of polyvinyl pyrrolidone molecular weights on the formation of nanosized silver colloids. Mater Chem Phys 2004; 83: 82-88.
33. Luo C, Zhang Y, Zeng X, et al. The role of poly(ethylene glycol) in the formation of silver nanoparticles. J Colloid Interface Sci 2005; 288: 444-448.
34. Ma M, Zhan Y, Shen Y, et al. Synthesis of amino-group functionalized superparamagnetic iron oxide nanoparticles and applications as biomedical labeling probes. J Nanopart Res 2011; 13: 3249-3257.
35. Mansur HS, Oréfice RL and Mansur AAP. Characterization of poly(vinyl alcohol)/poly(ethylene glycol) hydrogels and PVA-derived hybrids by small-angle X-ray scattering and FTIR spectroscopy. Polymer 2004; 45: 7193-7202.
36. Da Silva EC, Da Silva MGA, Meneghetti SMP, et al. Synthesis of colloids based on gold nanoparticles dispersed in castor oil. J Nanopart Res 2008; 10: 201-208.
37. Shameli K, Ahmad M, Wan Yunus WMZ, et al. Silver/poly(lactic acid) nanocomposites: preparation, characterization, and antibacterial activity. Int J Nanomedicine 2010; 5: 573-579.
38. Younes H and Cohn D. Phase separation in poly(ethylene glycol)/poly(lactic acid) blends. Eur Polym J 1988; 24: 765-773.
39. Agarwal M, Koelling KW and Chalmers JJ. Characterization of the degradation of polylactic acid polymer in a solid substrate environment. Biotechnol Progr 1998; 14: 517-526.
40. Shu Z and Wang S. Synthesis and characterization of magnetic nanosized Fe3O4/MnO2 composite particles. J Nanomater 2009; 5: 1-5.
41. Shameli K, Ahmad M, Jazayeri SD, et al. Investigation of antibacterial properties silver nanoparticles prepared via green method. Chem Cent J 2012; 73: 2-10.
42. Eken AE and Ozenbas M. Characterization of nanostructured magnetite thin films produced by sol-gel processing. J Sol-Gel Sci Techn 2009; 50: 321-327.
43. 4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126: 273-279.
44. 4 microparticles. Chem Mater 2009; 21: 5079-5087.
45. Zhang L, Shen Y, Xie A, et al. One-step synthesis of monodisperse silver nanoparticles beneath vitamin E Langmuir monolayers. J Phys Chem B 2006; 110: 6615-6620.
46. Li S, Shen Y, Xie A, et al. Green synthesis of silver nanoparticles using Capsicum annuum L. extract. Green Chem 2007; 9: 852-858.
47. Chatterjee S, Bandyopadhyay A and Sarkar K. Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application. J Nanobiotechnol 2011; 9: 34-40.
48. Vlerken LE and Amiji MM. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv 2006; 3: 205-216.
49. Lee JH, Jang JT, Choi JS, et al. Exchange-coupled magnetic nanoparticles for efficient heat induction. Nat Nanotechnol 2011; 6: 418-422.
50. Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, et al. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 2008; 10: 1343-1348.
51. Li W, Xie X, Shi S, et al. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals 2011; 24: 135-141.
52. Service RF. American Chemical Society meeting: nanomaterials show signs of toxicity. Science 2003; 300: 243.
53. Hoet PH, Bruske-Hohlfeld I and Salata OV. Nanoparticles - known and unknown health risks. J Nanobiotechnol 2004; 2: 12-26.
54. Kohanski MA, Dwyer DJ, Hayete B, et al. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797-810.
55. AshaRani PV, Kah Mun GL, Hande MP, et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009; 3: 279-290.
56. Ahamed M, Karns M, Goodson M, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008; 233: 404-410.
57. Ahamed M, Posgai R, Gorey TJ, et al. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophilia melanogaster. Toxicol Appl Pharmacol 2010; 242: 263-269.
58. Xie J, Xu C, Kohler N, et al. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced nonspecific uptake by macrophage cells. Adv Mater 2007; 19: 3163-3166.
59. Braydich-Stolle L, Hussain S, Schlager JJ, et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005; 88: 412-419.
60. Fathima NN, Rajaram A, Sreedhar B, et al. The formation of copper oxide nanorods in the presence of various surfactant micelles. Ind J Sci Technol 2008; 1: 1-6.
61. Wang W, Zhan Y and Wang G. One-step, solid-state reaction to the synthesis of copper oxide nanorods in the presence of a suitable surfactant. Chem Comm 2001; 8: 727-728.
62. Morteza M, Simchi A and Imani M. Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J Phys Chem C 2009; 113: 9573-9580.